Welcome to our dedicated page for Evolv Technologies Hldngs SEC filings (Ticker: EVLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing how Evolv Technologies turns cloud subscriptions and advanced sensors into sustained cash flow isn’t easy—its annual report alone tops 300 pages. If you have ever searched for “Evolv Technologies SEC filings explained simply” or wondered where deferred revenue is hiding, you know the challenge. Stock Titan’s AI reads every line the moment it hits EDGAR and converts dense accounting language into clear insights you can act on.
Tap into real-time coverage of every document type. Our platform links “Evolv Technologies quarterly earnings report 10-Q filing” to concise margin breakdowns, tags each “Evolv Technologies 8-K material events explained”, and delivers alerts for “Evolv Technologies Form 4 insider transactions real-time”. Need context fast? AI-powered summaries highlight how sensor R&D affects gross profit, while side-by-side views let you compare periods without scrolling through PDF footnotes.
Whether you’re tracking “Evolv Technologies insider trading Form 4 transactions” before a contract win, dissecting backlog trends in the “Evolv Technologies annual report 10-K simplified”, or checking the “Evolv Technologies proxy statement executive compensation” for alignment with growth, Stock Titan keeps critical data at your fingertips. Practical benefits include:
- AI summaries that make “understanding Evolv Technologies SEC documents with AI” effortless
- Drill-downs into “Evolv Technologies earnings report filing analysis” across segments
- One-click export of “Evolv Technologies executive stock transactions Form 4” for modelling
No more manual downloads or missed filings—our system refreshes the moment Evolv uploads, so you stay ahead of every disclosure that moves the stock.
Evolv Technologies (EVLV) reported a quarter marked by accounting restatements, ongoing legal and regulatory matters, and continued operating losses despite product launches and financing. The company restated prior-period condensed consolidated financial statements after an internal investigation found extra-contractual terms that affected revenue recognition and led to personnel changes. Evolv had $36.9 million in cash, cash equivalents, and marketable securities as of June 30, 2025, and expects that, together with expected cash from operations and borrowing availability under newly negotiated Senior Secured Credit Facilities, it has at least twelve months of liquidity. The company recorded a net loss of $42.2 million for the six months ended June 30, 2025, recognized restructuring charges related to a reduction in force, and disclosed material weaknesses in internal controls with an active remediation plan. Significant contingencies include shareholder class and derivative actions, FTC and SEC matters, and an estimated $15.0 million settlement accrual for the class action with an expected $14.0 million insurance recovery.
Michael Ellenbogen, Founder & Chief Innovation Officer and Director of Evolv Technologies Holdings, reported significant changes in beneficial ownership on June 23, 2025. The key transaction involved the transfer of investment control of 2,259,987 shares of Class A Common Stock previously held by E Ventures Trust to an independent investment advisor.
Following this transaction, Ellenbogen's holdings include:
- 2,083,961 shares held directly
- 151,135 shares held indirectly through Family Horizon Trust
The transfer of investment control means Ellenbogen no longer has beneficial ownership of the E Ventures Trust shares and will not include them in future Section 16 reports. This represents a significant change in his control over company shares while maintaining his executive and board positions.
Evolv Technologies Holdings (NASDAQ: EVLV) filed a Form 4 detailing routine equity movements by director Richard A. Shapiro. On June 19 2025 he acquired 12,515 Class A shares at $0 when a prior restricted stock unit (RSU) award vested. A day later, on June 20 2025, he received a new grant of 27,050 RSUs that will vest in full on the earlier of June 20 2026 or the day before the next annual meeting. Following these transactions Shapiro now holds 22,515 shares directly, plus indirect interests—30,000 shares held by his spouse, 15,000 in a trust, and 7,600 in a spouse retirement plan—for a combined indirect total of 52,600 shares. No shares were sold, and the transactions represent standard non-employee director compensation rather than open-market purchases or sales.
Evolv Technologies (NASDAQ:EVLV) filed a routine Form 4 disclosing an equity award to director Neil Glat. On June 20, 2025, Glat received 27,050 Restricted Stock Units (RSUs), each representing one share of Class A common stock. The RSUs carry no exercise price and will vest in full on the earlier of June 20, 2026 or the day immediately preceding the company’s next annual meeting. Following the grant, Glat beneficially owns 27,050 shares directly. No sales, dispositions, or other material transactions were reported.
FAQ
What is the current stock price of Evolv Technologies Hldngs (EVLV)?
What is the market cap of Evolv Technologies Hldngs (EVLV)?
